Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morimoto

Showing results (571-580 of 594) with videos related to

Pageof 60
Sort By:
Elife|April 21, 2021
Creating and controlling visual environments using BonVisionGonçalo Lopes, Karolina Farrell, Edward Ab Horrocks, et al.
Journal of Medical Primatology|May 7, 2010
Tetraparesis resembling acute transverse myelitis in a captive chimpanzee (Pan troglodytes): long-term care and recoveryT Miyabe-Nishiwaki, A Kaneko, K Nishiwaki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2018
Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma RiskChenan Zhang, Joseph L Wiemels, Helen M Hansen, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of <i>TP53</i> status in gemcitabine plus nab-paclitaxel therapyM Sugimori, A Hirotani, H Yamazaki, et al.
Molecular Pharmaceutics|November 17, 2018
In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery ApproachesKelly M Loyet, Philip E Hass, Wendy N Sandoval, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 26, 1998
[SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma]K Numata, K Tanaka, T Kiba, et al.
Cancer|October 13, 2018
Genetic determinants of childhood and adult height associated with osteosarcoma riskChenan Zhang, Libby M Morimoto, Adam J de Smith, et al.
Leukemia|November 9, 2021
Genome-wide trans-ethnic meta-analysis identifies novel susceptibility loci for childhood acute lymphoblastic leukemiaSoyoung Jeon, Adam J de Smith, Shaobo Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2017
Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et alM Ikeda, S Shimizu, T Sato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2016
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trialM Ikeda, S Shimizu, T Sato, et al.
Pageof 60

Showing results (571-580 of 594) with videos related to

Sort By:
Pageof 60
Elife|April 21, 2021
Creating and controlling visual environments using BonVisionGonçalo Lopes, Karolina Farrell, Edward Ab Horrocks, et al.
Journal of Medical Primatology|May 7, 2010
Tetraparesis resembling acute transverse myelitis in a captive chimpanzee (Pan troglodytes): long-term care and recoveryT Miyabe-Nishiwaki, A Kaneko, K Nishiwaki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2018
Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma RiskChenan Zhang, Joseph L Wiemels, Helen M Hansen, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of <i>TP53</i> status in gemcitabine plus nab-paclitaxel therapyM Sugimori, A Hirotani, H Yamazaki, et al.
Molecular Pharmaceutics|November 17, 2018
In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery ApproachesKelly M Loyet, Philip E Hass, Wendy N Sandoval, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 26, 1998
[SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma]K Numata, K Tanaka, T Kiba, et al.
Cancer|October 13, 2018
Genetic determinants of childhood and adult height associated with osteosarcoma riskChenan Zhang, Libby M Morimoto, Adam J de Smith, et al.
Leukemia|November 9, 2021
Genome-wide trans-ethnic meta-analysis identifies novel susceptibility loci for childhood acute lymphoblastic leukemiaSoyoung Jeon, Adam J de Smith, Shaobo Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2017
Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et alM Ikeda, S Shimizu, T Sato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2016
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trialM Ikeda, S Shimizu, T Sato, et al.
Pageof 60